NAD(P)+ nucleosidase (3.2.2.6)

Follow

Industry

CPC
C12Y302/02006

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y302/00Hydrolases acting on glycosyl compounds

Current Industry

C12Y302/02006NAD(P)+ nucleosidase (3.2.2.6)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Site-specific antibody-drug conjugates by ADP-ribosyl cyclases
- Patent number 11,684,676
- Issue date Jun 27, 2023
- University of Southern California
- Yong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES
- Publication number 20230128344
- Publication date Apr 27, 2023
- University of Southern California
- Yong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ADP-RIBOSYL CYCLASE AND INHIBITOR THEREOF
- Publication number 20220235343
- Publication date Jul 28, 2022
- INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY
- Uh-Hyun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of CD83 in Combination Therapies
- Publication number 20160008440
- Publication date Jan 14, 2016
- Argos Therapeutics, Inc.
- Charles Nicolette
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of CD83 in combination therapies
- Publication number 20140010821
- Publication date Jan 9, 2014
- Charles Nicolette
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...